- Home
- ESEA vs VYGR Comparison
ESEA vs VYGR Comparison
Compare ESEA & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- VYGR
- Stock Information
- Founded
- ESEA 2005
- VYGR 2013
- Country
- ESEA Greece
- VYGR United States
- Employees
- ESEA N/A
- VYGR N/A
- Industry
- ESEA Marine Transportation
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- ESEA Consumer Discretionary
- VYGR Health Care
- Exchange
- ESEA Nasdaq
- VYGR Nasdaq
- Market Cap
- ESEA 293.8M
- VYGR 309.7M
- IPO Year
- ESEA 2006
- VYGR 2015
- Fundamental
- Price
- ESEA $35.71
- VYGR $6.27
- Analyst Decision
- ESEA Buy
- VYGR Strong Buy
- Analyst Count
- ESEA 1
- VYGR 9
- Target Price
- ESEA $53.00
- VYGR $16.44
- AVG Volume (30 Days)
- ESEA 41.3K
- VYGR 501.0K
- Earning Date
- ESEA 11-20-2024
- VYGR 11-12-2024
- Dividend Yield
- ESEA 6.72%
- VYGR N/A
- EPS Growth
- ESEA 3.12
- VYGR N/A
- EPS
- ESEA 16.28
- VYGR 0.47
- Revenue
- ESEA $208,648,067.00
- VYGR $163,784,000.00
- Revenue This Year
- ESEA $13.93
- VYGR N/A
- Revenue Next Year
- ESEA $5.41
- VYGR N/A
- P/E Ratio
- ESEA $2.20
- VYGR $13.45
- Revenue Growth
- ESEA 13.90
- VYGR 3.40
- 52 Week Low
- ESEA $26.49
- VYGR $5.19
- 52 Week High
- ESEA $50.92
- VYGR $11.72
- Technical
- Relative Strength Index (RSI)
- ESEA 31.57
- VYGR 49.10
- Support Level
- ESEA $37.37
- VYGR $6.08
- Resistance Level
- ESEA $40.73
- VYGR $6.44
- Average True Range (ATR)
- ESEA 1.59
- VYGR 0.34
- MACD
- ESEA -0.34
- VYGR 0.04
- Stochastic Oscillator
- ESEA 3.85
- VYGR 38.42
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.